RE:RE:RE:somethings gotta give...@Plantrader- Like you and a couple of others here, I'm sipping the Koolaid from a very small straw. I really hope the optimistic views expressed here come true but I also keep noticing how the wording with each NR subtly adds in delays. Both for ACT and vaccine. Something about not being able to raise any money in the last round still rankles with me. And I've been through this almost exact situation with another company. This time, I'm hoping it's different. I welcome the dialogue with many of the balanced folks here and have learned to tune out the optimistic squirrels on steroids. Let's hope for the best in Q1. I give it a 50% probability they will get BTD in Q1. Happy to eat my shoes if they do
plantrader wrote: Would that mean we think Dr Mandel was sandbagging in the recent article? Since he said the company expects to get into talks with big biopharma in 2023/24? If they were already in advanced talks why would he make it sound like it hasn't started yet?
Maybe misdirection is common in a situation like this, I personally don't know. But this seems similar to expecting BTD in Feb when the Mandel says they expect to "apply" in 1Q 2023. I doubt that means they applied in the first week of January.
Rumpl3StiltSkin wrote: Yajne wrote: I've gotta believe that TLT hasn't shown all of their cards to address the financing issue that's soon approaching. My math suggests they raised enough pp funds to get to the end of Q1 (Mar31/23). They must already know of a JV in the works or something to remain solvent past Q1. I'm optimistic that there is a game plan in the works, but something definitely has gotta give soon...GLTA all longs!!
Either way though, whenever that $ is gonna run out. I think they will have a much higher SP by then. And I also think you are right about advanced $ talks with some Bio/Pharma...